Doliprane Vitamine C is generally applied across therapeutic domains where short-term symptom management is appropriate, focusing on providing symptomatic relief and supportive benefits during periods of acute discomfort or illness.

Management of Pain and Elevated Temperature

This formulation is commonly used in clinical settings that involve acute symptom patterns, targeting the core symptoms of pain and fever. Its primary action is relevant for easing mild to moderate pain, which includes common manifestations like headaches, muscle aches, and dental discomfort. It is also relevant for easing elevated body temperature. The medication is generally used to help relieve mild to moderate pain and reduce fever. This is commonly used when short-term symptomatic assistance is needed, and the relief contributes to improved comfort during periods of heightened symptoms.

Relief from Symptom Clusters in Viral Illness

The medication is relevant in conditions characterized by periods of heightened symptoms, such as those associated with seasonal illnesses (colds and flu). It helps address symptom clusters that may become intense or disruptive, specifically when fever and general body malaise occur together. This is commonly used when short-term symptomatic assistance is needed, and the relief assists with easing symptoms that may interfere with daily functioning.

---

Quick Fact: Relief for Pain and Fever

Property	Description
Primary Use	Relevant for easing mild to moderate pain and fever.
Symptom Areas	Supports management of symptoms related to systemic imbalance and physical discomfort.
Context	Applied in acute or episodic symptomatic phases.
Supportive Benefit	Contributes to general well-being during symptomatic periods.

Regulatory References

1. NIH MedlinePlus Drug Information on Acetaminophen

Eligibility Map: Who can and cannot use Doliprane Vitamine C — official regulatory information

The eligibility for this fixed-dose combination product, containing Paracetamol and Ascorbic Acid, is strictly determined by governmental regulatory labeling based on patient risk profile, organ function, and age.

---

Eligibility scope

Classification	Eligible or Non-Eligible Populations
Populations for whom use is allowed	Adults and adolescents over a specific weight/age threshold (e.g., typically ge 15 years or ge 50 kg).
Populations for whom use is not recommended	Children below the minimum approved age/weight for the formulation (e.g., under 16 years).
Populations for whom use is contraindicated	Patients with known hypersensitivity to Paracetamol, Ascorbic Acid, or any excipients. Patients with severe hepatic impairment or severe renal impairment. Patients with a history of renal lithiasis (kidney stones), particularly at high doses of Vitamin C.

Age-related eligibility rules: The product is not recommended for children under the specified age (e.g., 16 years). Use in older adults generally follows adult rules, but caution is advised due to potential age-related organ decline.

Condition-specific eligibility rules: Contraindication applies to severe hepatic or severe renal impairment. Conditional use is mandated for mild to moderate hepatic insufficiency, chronic alcoholism, malnutrition, or conditions leading to glutathione depletion.

Pregnancy and lactation eligibility status: Use is permitted but is conditional, requiring the lowest effective dose for the shortest duration necessary.

Eligibility-related restrictions: Caution is required for patients on a low-salt diet due to the sodium content in effervescent tablets, and for patients with phenylketonuria (PKU) if the product contains aspartame.

---

Resulting eligibility structure

Official regulatory documents define who can and cannot use this medicine by establishing non-negotiable contraindications (e.g., organ failure, allergy) and outlining risk-based restrictions for populations with pre-existing conditions that affect the clearance and toxicity profile of Paracetamol.

The official interaction profile for this combination product is defined by constraints related to both Acetaminophen (Paracetamol) and Ascorbic Acid (Vitamin C), as stated in authoritative regulatory documentation.

Documented Interaction Classifications

Classification	Interacting Agent	Official Concern / Effect
Contraindicated	Other Paracetamol-Containing Products	Risk of cumulative dose and severe hepatotoxicity.
Risk Restriction	Ethanol (Alcohol)	Increased risk of severe liver damage.
Pharmacodynamic	Warfarin and other Coumarins	Prolonged use may enhance the anticoagulant effect.

Pharmacokinetic and Population-Specific Notes

Certain medicines can affect the exposure of the active ingredient. Metoclopramide and Domperidone increase the rate of Acetaminophen absorption, whereas Cholestyramine reduces it. Ascorbic acid is associated with the diminution of Ciclosporine blood concentrations and may reduce the efficacy of certain antibiotics.

Specific population restrictions exist, notably for the Paracetamol component in individuals with Severe Hepatic Impairment, who are at increased toxicity risk. For the Vitamin C component, individuals with G6PD Deficiency are warned of the potential for hemolysis with high doses. Mandatory labeling requires a minimum interval of 4 hours between administrations.

Modulation of Prostaglandin Synthesis

The action of paracetamol (acetaminophen) is primarily exerted within the central nervous system (CNS) through the inhibition of cyclooxygenase (COX) enzymes. This targeted enzyme inhibition initiates a signaling sequence that reduces the synthesis and subsequent release of prostaglandins. Prostaglandins act as key endogenous mediators associated with specific physiological responses, and their reduced production results in altered systemic signaling within central regulatory pathways.

---

Engagement of Redox and Metabolic Processes

Ascorbic acid (Vitamin C) operates through distinct biochemical pathways. It acts as a water-soluble antioxidant, engaging mechanisms of free-radical scavenging and reduction of reactive oxygen species. Furthermore, ascorbic acid is an essential cofactor in numerous enzymatic hydroxylation and amidation reactions. This cofactor activity contributes to specific metabolic processes and modulates the localized levels of specific mediators, influencing intracellular signaling integrity.

Doliprane Vitamine C is a fixed-dose combination product containing Paracetamol 500 mg and Ascorbic Acid 150 mg designed exclusively for oral administration. Its usage is strictly governed by quantitative limits and procedural requirements outlined in regulatory documents.

Administration and Dosing

For adults weighing 50 kg and over, the standard single dose is 500 mg to 1000 mg of Paracetamol (1 to 2 tablets). The minimum interval required between any two doses is 4 hours. The total daily intake is typically limited to a maximum of 3000 mg (6 tablets), though a maximum of 4000 mg is permissible only with prior medical consultation.

Preparation and Timing Constraints

The effervescent tablet must be completely dissolved in a large glass of water, and the resulting solution must be consumed immediately upon preparation. It is an official procedural constraint to avoid taking the medication in the late afternoon or evening, as the Ascorbic Acid component has slightly stimulating properties.

Usage Duration and Adjustments

The use of this medication is regulated by strict duration limits: treatment should not exceed 5 days for pain or 3 days for fever. For adults weighing less than 50 kg or those with moderate hepatic or severe renal impairment, the maximum daily dose is reduced to 3000 mg Paracetamol. Severe renal impairment also requires extending the minimum dosing interval to 8 hours.

Paracetamol and Vitamin C Combination: Overview of Clinical Evidence

Doliprane Vitamine C contains the established analgesic and antipyretic agent, paracetamol (acetaminophen), along with ascorbic acid (Vitamin C). The primary clinical function of the product is derived from paracetamol, which is widely recognized as a first-line treatment for the temporary relief of mild-to-moderate pain and fever, including symptoms associated with headaches, flu-like illness, and body aches.

Research Focus on the Combination

Research on the combination of paracetamol and Vitamin C has focused on two main areas: pharmacokinetics and adjunctive therapy.

• Pharmacokinetics and Absorption: Studies exploring the combined administration have investigated whether Vitamin C influences the body's processing of paracetamol. Some data suggest that co-administration may affect the absorption profile of paracetamol, potentially leading to a higher maximum measured concentration ( C max) in specific bodily fluids, which could increase the potential for drug-drug interaction or risk of side effects, especially in cases of overdose.

• Adjunctive Effects: Ascorbic acid is included for its role as a water-soluble vitamin and antioxidant. In the context of pain and fever treatments, Vitamin C is considered an adjunct. While paracetamol’s efficacy is well-established, some observational and preclinical studies have explored whether the antioxidant properties of Vitamin C may offer protective effects, such as against paracetamol-induced oxidative stress in certain organs, particularly at high doses. However, the addition of Vitamin C does not alter the principal analgesic or antipyretic mechanism of paracetamol.

Efficacy and Safety

Clinical trials directly comparing the combination product (paracetamol + Vitamin C) to paracetamol alone have yielded mixed results regarding symptomatic relief. The overall benefit in pain and fever reduction is attributable to the paracetamol component. Safety profiles primarily reflect the known risks of paracetamol, which include the potential for hepatotoxicity in cases of excessive dosing, regardless of the presence of Vitamin C.

Key Studies & References Recommended paracetamol doses (TGA Guidance for Analgesic/Antipyretic Use)

Common questions about Doliprane Vitamine C (FAQ)

---

Q: What is the function of the Vitamin C in the treatment of pain or fever?

The core function of this medicine in treating pain and fever is carried out by the Paracetamol component. The official product information describes the Ascorbic Acid (Vitamin C) component as an adjunct and a supplementary nutritional agent that provides antioxidant properties. Its inclusion is not intended to alter the primary pain or fever-reducing actions of the Paracetamol.

---

Q: What is the difference between this product and a product containing only paracetamol?

The primary difference lies in the presence of Ascorbic Acid (Vitamin C). This product is a fixed-dose combination, meaning it contains both the therapeutic agent, Paracetamol, and the nutritional agent, Vitamin C. The standard Paracetamol product contains only the pain and fever-reducing component.

---

Q: What kind of studies have been done on the combination of paracetamol and Vitamin C?

Official regulatory summaries indicate that research on this specific drug combination has focused on two main areas. One focus is pharmacokinetics, which investigates how the body processes the two active ingredients together. The other area is adjunctive therapy, which examines the use of Vitamin C as a supplement alongside the established effects of Paracetamol.

---

Q: Is the research on the effectiveness of paracetamol widely accepted?

Yes. According to health authorities, the effectiveness of Paracetamol (Acetaminophen) as a first-line agent for the temporary relief of mild-to-moderate pain and fever is widely accepted and recognized. The ingredient itself is considered established and efficacious for these uses.

---

Q: Is it described as a cure for the common cold?

No. The official product labeling does not describe this medicine as a cure for the common cold or flu. It is indicated only for the symptomatic relief of discomfort, such as pain, body aches, and fever, that can be associated with flu-like illness.

---

Q: Is it true that Doliprane Vitamine C can affect blood tests?

Yes, official safety information indicates that the Ascorbic Acid component can interfere with certain clinical tests. This interference may affect the results of tests for urinary glucose, blood glucose screening, and the detection of occult blood in stool samples.

---

Q: Does taking this medication affect driving or operating machinery?

Official regulatory documents generally state that the active ingredients, Paracetamol and Ascorbic Acid, are not known to impair an individual's ability to drive or operate machinery. However, patients should be mindful of their individual response to any medication.

---

Q: What happens if I take more than the recommended amount by accident?

Official guidance instructs that if an accidental overdose is suspected, one should seek immediate medical advice or contact a poison control center right away, even if they currently feel well. This is crucial because an overdose of the Paracetamol component carries a significant risk of delayed, severe liver damage.

---

Q: How long can a person expect the pain relief effects to last?

The expected duration of the pain-relieving effects, based on the Paracetamol component, is generally up to 3 to 4 hours in most people. This duration can vary between individuals and is a factor in determining the required minimum dosing interval.

---

Q: Does taking Doliprane Vitamine C cause sleeplessness or insomnia?

While the product contains Vitamin C, which is sometimes associated with a mild lift, insomnia (difficulty sleeping) has been cited as a possible, though generally uncommon, adverse reaction in the safety data for products containing Paracetamol. Regulatory information advises considering overall side effect profiles.

---

Q: Is it normal to feel tired after taking this medication?

Regulatory documents list side effects related to paracetamol-containing products. In some contexts, fatigue or asthenia (lack of energy) has been included as a possible, but not commonly reported, adverse reaction. This possibility is noted in safety summaries.

---

Q: Are long-term effects of taking Doliprane Vitamine C known?

Official warnings and precautions state that chronic, regular use is discouraged over long periods. This is due to documented associations with adverse effects, including potential medication-overuse headache and possible long-term alteration of kidney function.

---

Q: What should be done if someone misses a time to take the medicine?

Official instructions generally describe taking the next dose at the usual time and avoiding doubling the dose to make up for a missed one. The required minimum dosing interval, as defined by the product label, must always be respected.

---

Q: Does Doliprane Vitamine C interact with herbal supplements?

Regulatory guidance on drug interactions often advises patients to inform their doctor or pharmacist about all concomitant herbal remedies, supplements, and complementary medicines. This ensures proper evaluation of potential interactions, as specific herbal supplements are not universally tested with this combination.

---

Q: Can people with thyroid conditions use this medicine?

General regulatory documents indicate that Paracetamol products are not usually contraindicated for thyroid conditions. However, a caution exists that certain thyroid medications (like levothyroxine) may require a separation of at least 4 hours from multivitamin products due to potential interference with drug absorption.

---

Q: Can I take Doliprane Vitamine C if I am taking medicines for gout?

Paracetamol is generally regarded as safe to take with common gout medications. However, official safety notes related to the Ascorbic Acid component point out that high doses of Vitamin C may be associated with an increased potential for renal stone formation (kidney stones) in predisposed individuals.

---

Q: How does the onset of action compare to standard paracetamol tablets?

Effervescent formulations are described as potentially having a more rapid absorption compared to standard tablets, as the substance is already dissolved before ingestion. This difference in formulation is the main factor influencing the speed of absorption.

---

Q: Why do some forms of Doliprane Vitamine C dissolve in water?

Effervescent formulations are used to make the medicine easier to take for individuals who may have difficulty swallowing tablets. Official reviews note that this format allows the medicine to be dissolved before ingestion, which is understood to support potentially quicker absorption.

---

Q: Is there evidence to suggest Vitamin C affects paracetamol absorption?

Official summaries of research indicate that co-administration has been studied and suggests the Vitamin C component may influence the absorption profile of Paracetamol. The specific impact is a subject regulatory bodies have examined.

The official regulatory requirements for storing and disposing of Doliprane Vitamine C (Paracetamol/Acetaminophen and Ascorbic Acid) focus on maintaining drug stability, safety, and environmental protection.

Storage Requirements

Item	Requirement
Temperature	Store at a temperature not exceeding 25 C.
Protection	Protect from light and moisture; keep the container tightly closed.
Handling	Do not freeze the product.
Safety	Keep out of the sight and reach of children.

Disposal Requirements

Disposal must align with pharmaceutical waste protocols. The product must not be thrown away with household waste or disposed of via wastewater (flushed down the toilet or poured down the sink). Patients are instructed to ask their pharmacist for the approved method of discarding unused or expired medicine.